Hims Hers Health

Hims Hers Health

Yahoo Finance • 18 hours ago

Principal US Small-Cap ETF Experiences Big Inflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Principal US Small-Cap ETF (Symbol: PSC) where we have detected an approximate $419.9 million dollar inflow -... Full story

Yahoo Finance • 7 days ago

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?

Key Points Hims & Hers Health continues to drive impressive growth through its subscription-based consumer wellness platform. Teladoc Health maintains a dominant market share with over 100 million global members and significant institutio... Full story

Yahoo Finance • 21 days ago

Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the latest close session, Hims & Hers Health, Inc. (HIMS) was down 1.73% at $32.96. The stock's performance was behind the S&P 500's daily loss of 1.44%. On the other hand, the Dow registered a loss of 0.09%, and the technology-centric... Full story

Yahoo Finance • 21 days ago

Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Hims & Hers Health (NYSE:HIMS) is expanding its GLP-1 weight-loss treatment offerings, adding ne... Full story

Yahoo Finance • 21 days ago

2 Unpopular Stocks That Deserve a Second Chance and 1 We Question

2 Unpopular Stocks That Deserve a Second Chance and 1 We Question Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate r... Full story

Yahoo Finance • 22 days ago

1 Surging Stock Worth Your Attention and 2 We Find Risky

1 Surging Stock Worth Your Attention and 2 We Find Risky Great things are happening to the stocks in this article. They're all outperforming the market over the last month because of positive catalysts such as a new product line, constru... Full story

Yahoo Finance • 26 days ago

Living Longer Is Big Business. These Stocks Will Benefit.

TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion. Continue Reading... Full story

Yahoo Finance • 26 days ago

Hims & Hers Rallies With a July FDA Decision Looming

This article first appeared on GuruFocus. Hims & Hers Health (NYSE:HIMS) rose 6.46% intraday after a Barclays upgrade continued to drive buying, with analyst Glen Santangelo raising his price target to $39 from $29 while maintaining an Ov... Full story

Yahoo Finance • 28 days ago

Hims & Hers (HIMS) Climbs 12.5% as Obesity Market Momentum Builds

Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks Stealing the Spotlight from Wall Street Giants. Hims & Hers rallied by 12.49 percent on Monday to finish at $30.17 apiece, as investors cheered rosy growth prospects for the obes... Full story

Yahoo Finance • last month

The GLP-1 stock nobody is pricing in isn’t a drugmaker

Quick Read $LLY printed $19.8B in Q1 revenue (+55% YoY) as GLP-1 demand chemically reshapes the same market $AMZN's pharmacy is quietly capturing. $HIMS absorbed a $92M Q1 loss exiting compounded GLP-1s but raised 2026 revenue guidance to... Full story

Yahoo Finance • last month

Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $27.71, moving -4.38% from the previous trading session. This change lagged the S&P 500's 1.62% loss on the day. Meanwhile, the Dow experienced a drop of 1.87%, and the... Full story

Yahoo Finance • last month

Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?

Is HIMS a good stock to buy? We came across a bearish thesis on Hims & Hers Health, Inc. on Valueinvestorsclub.com by Pridwen. In this article, we will summarize the bears’ thesis on HIMS. Hims & Hers Health, Inc.'s share was trading at $2... Full story

Yahoo Finance • last month

Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock

Hims & Hers Health (NYSE: HIMS) is trying to turn GLP-1 demand, subscriber growth, and international expansion into a much larger healthcare platform. The stock has dropped sharply, margins are under pressure, and valuation still looks dem... Full story

Yahoo Finance • last month

Political Scrutiny Tests Hims And Hers GLP1 Weight Loss Growth Story

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. U.S. Senator Jim Banks has publicly urged the FDA to review Hims &... Full story

Yahoo Finance • last month

Hims & Hers Expands With Eucalyptus Acquisition

This article first appeared on GuruFocus. Hims & Hers Health Inc. (HIMS, Financials) completed its acquisition of Eucalyptus, giving the telehealth company a larger international footprint in Australia, Canada and Japan. Warning! GuruFoc... Full story

Yahoo Finance • last month

Is Hims & Hers Stock an Undervalued Stock to Buy?

Hims & Hers(NYSE: HIMS) is one of the most volatile stocks in the market. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the cri... Full story

Yahoo Finance • 2 months ago

Hims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot

Hims & Hers Health shares have slumped in 2026 as the telehealth provider moves away from selling compounded GLP-1 medications. Continue Reading... Full story

Yahoo Finance • 2 months ago

How The Hims & Hers Health (HIMS) Story Is Shifting With GLP‑1 Hopes And Margin Questions

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The blended fair value estimate for Hims & Hers Health has moved from US$24.31 to US$26.82 per sha... Full story

Yahoo Finance • 2 months ago

Hims & Hers Prices Upsized $350 Million Convertible Notes Offering

This article first appeared on GuruFocus. Hims & Hers Health (NYSE:HIMS) has priced a larger $350 million private offering of 0.00% convertible senior notes due 2032, up from the previously announced $300 million size, giving investors a... Full story

Yahoo Finance • 2 months ago

Hims & Hers Health prices $350M senior convertible notes

* Hims & Hers Health (HIMS) priced [https://seekingalpha.com/pr/20519597-hims-and-hers-health-inc-prices-upsized-350-million-convertible-senior-notes-offering-to] its offering of $350M aggregate principal amount of 0.00% convertible seni... Full story